Patents Assigned to Conpharm AB
  • Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
    Patent number: 5637571
    Abstract: This invention relates to the treatment of a host afflicted with a state of secondary amyloidosis using certain acetals of podophyllotoxin-.beta.-D-glucopyranoside.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: June 10, 1997
    Assignees: Conpharm AB, Analytecon SA
    Inventors: Borje Rosen, Kurt Leander
  • Medicinal uses for podophyllotoxins
    Patent number: 4788216
    Abstract: The invention relates to compounds consisting of podophyllotoxin and its derivatives of the formula ##STR1## wherein R.sub.1 is H or OH and R.sub.2 is H or CH.sub.3, for treatment of psoriasis, malaria and rheumatoid arthritis and to a method for their preparation. Furthermore, the invention concerns the use of the compounds for treatment of said states of illness, as well as the use of said compounds for the preparation of pharmacological compositions for the treatment of said states of illness.
    Type: Grant
    Filed: August 28, 1986
    Date of Patent: November 29, 1988
    Assignee: Conpharm AB
    Inventors: Kurt Leander, Borje Rosen